Aridis Pharmaceuticals, Inc. (ARDS)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Mar 31, 2025

Aridis Pharmaceuticals Statistics

Total Valuation

ARDS has a market cap or net worth of 5,332. The enterprise value is 4.81 million.

Market Cap 5,332
Enterprise Value 4.81M

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date Apr 25, 2025
Ex-Dividend Date n/a

Share Statistics

ARDS has 53.32 million shares outstanding.

Current Share Class n/a
Shares Outstanding 53.32M
Shares Change (YoY) n/a
Shares Change (QoQ) +2.26%
Owned by Insiders (%) 4.36%
Owned by Institutions (%) 9.69%
Float 44.14M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.00
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -4.21
EV / Sales 0.22
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -0.27

Financial Position

The company has a current ratio of 0.24

Current Ratio 0.24
Quick Ratio 0.03
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -0.27
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -4.40%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 5.99%
Revenue Per Employee 604,297
Profits Per Employee -30,865
Employee Count 37
Asset Turnover 2.40
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -99.87% in the last 52 weeks. The beta is -80.53, so ARDS's price volatility has been lower than the market average.

Beta (5Y) -80.53
52-Week Price Change -99.87%
50-Day Moving Average 0.00
200-Day Moving Average 0.03
Relative Strength Index (RSI) 36.95
Average Volume (20 Days) 10,147

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.16

Income Statement

In the last 12 months, ARDS had revenue of 22.36 million and -1.14 million in losses. Loss per share was -0.04.

Revenue 22.36M
Gross Profit 5.21M
Operating Income -656,000
Pretax Income -1.14M
Net Income -1.14M
EBITDA -347,000
EBIT -656,000
Loss Per Share -0.04
Full Income Statement

Balance Sheet

The company has 35,000 in cash and 4.84 million in debt, giving a net cash position of -4.81 million or -0.09 per share.

Cash & Cash Equivalents 35,000
Total Debt 4.84M
Net Cash -4.81M
Net Cash Per Share -0.09
Equity (Book Value) -11.80M
Book Value Per Share -0.26
Working Capital -13.37M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -17.89 million and capital expenditures -49,000, giving a free cash flow of -17.93 million.

Operating Cash Flow -17.89M
Capital Expenditures -49,000
Free Cash Flow -17.93M
FCF Per Share -0.34
Full Cash Flow Statement

Margins

Gross margin is 23.28%, with operating and profit margins of -2.93% and -5.11%.

Gross Margin 23.28%
Operating Margin -2.93%
Pretax Margin -5.11%
Profit Margin -5.11%
EBITDA Margin -1.55%
EBIT Margin -2.93%
FCF Margin n/a

Dividends & Yields

ARDS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -88.34%
Shareholder Yield -88.34%
Earnings Yield -21,417.85%
FCF Yield -336,346.59%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ARDS has an Altman Z-Score of -39.72. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -39.72
Piotroski F-Score n/a